PHARMACOKINETICS OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS, WITH OR WITHOUT CIRRHOSIS

被引：0
|
作者：
Mao, Lily [1 ]
Bowlus, Christopher L. [2 ]
Levy, Cynthia [3 ]
Odin, Joseph
Stanca, Carmen M. [4 ]
Trivedi, Palak [5 ]
Varga, Monika [1 ]
Bergheanu, Sandrin [6 ]
Yang, Ke [1 ]
Steinberg, Alexandra [1 ]
Rossi, Stephen [1 ]
Boudes, Pol [1 ]
机构：
[1] Cymabay Therapeut, Newark, CA USA
[2] Univ Calif Davis, Dept Internal Med, Div Gastroenterol & Hepatol, Sacramento, CA 95817 USA
[3] Univ Miami, Miller Sch Med, Div Hepatol, Miami, FL 33136 USA
[4] NYU Hepatol Associates, New York, NY USA
[5] Univ Hosp Birmingham, Birmingham, W Midlands, England
[6] Saberg Clin Res BV, The Hague, Netherlands
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1328
引用
收藏
页码：807A / 808A
页数：2
相关论文
共 50 条
  • [1] Safety and Efficacy of Seladelpar in Primary Biliary Cholangitis Patients with Cirrhosis
    Bowlus, Christopher L.
    Hirschfield, Gideon
    Bacon, Bruce R.
    Galambos, Michael R.
    Harrison, Stephen A.
    Odin, Joseph
    Amato, Gianni
    Steinberg, Alexandra
    Rosenbusch, Scott
    Bergheanu, Sandrin
    Boudes, Pol
    [J]. HEPATOLOGY, 2018, 68 : 1077A - 1078A
  • [2] Seladelpar for primary biliary cholangitis
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (06): : 510 - 510
  • [3] Seladelpar for primary biliary cholangitis
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (05): : 414 - 414
  • [4] Seladelpar in primary biliary cholangitis
    Kotsiliti, Eleni
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (05) : 300 - 300
  • [5] Seladelpar in primary biliary cholangitis
    Eleni Kotsiliti
    [J]. Nature Reviews Gastroenterology & Hepatology, 2024, 21 : 300 - 300
  • [6] Seladelpar: New hope for patients with primary biliary cholangitis
    Nevzorova, Yulia A.
    Cubero, Francisco Javier
    [J]. MED, 2024, 5 (05): : 377 - 379
  • [7] Pharmacokinetics and pharmacodynamics of seladelpar, a potent and selective PPAR-delta, in patients with primary biliary cholangitis
    Boudes, P.
    Michael, G.
    Bowlus, C.
    Hirschfield, G.
    Jones, D.
    Odin, J.
    Sheridan, D.
    Gitlin, N.
    Harrison, S.
    Hassanein, T.
    Levy, C.
    Shiffman, M.
    Thorburn, D.
    Thuluvath, P. J.
    Vierling, J.
    Choi, Y. -J.
    Varga, M.
    Steinberg, A.
    Mcwherter, C.
    Martin, R.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S235 - S235
  • [8] Seladelpar in patients with primary biliary cholangitis: Need for a closer look!
    Mishra, Ajay Kumar
    Singh, Satender Pal
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 (05) : 1474 - 1474
  • [9] Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!"
    Bowlus, Christopher L.
    Levy, Cynthia
    Hirschfield, Gideon M.
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 (05) : 1452 - 1453
  • [10] Seladelpar for the treatment of primary biliary cholangitis: Experience with 26 cirrhotic patients
    Mayo, Marlyn J.
    Bowlus, Christopher
    Michael, Galambos
    Neff, Guy
    Trivedi, Palak
    Goel, Aparna
    Odin, Joseph
    Bacon, Bruce
    Borg, Brian
    Gordon, Stuart C.
    Gulamhusein, Aliya
    Harrison, Stephen
    Levy, Cynthia
    Stanca, Carmen
    Vierling, John
    Steinberg, Alexandra
    Varga, Monika
    Nguyen, Jaidyn
    Bergheanu, Sandrin
    Choi, Yun-Jung
    Standen, Mary
    Boudes, Pol
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E76 - E76
12345